Table 3 Adverse cardiovascular events in the study population during follow-up.
Total (n = 2648) | Q1 (n = 883) | Q2 (n = 882) | Q3 (n = 883) | p-value | |
|---|---|---|---|---|---|
MACE, (%) | 193 (7.3) | 46 (5.2) | 68 (7.7) | 79 (8.9) | 0.009 |
All cause death, (%) | 67 (2.5) | 19 (2.2) | 22 (2.5) | 26 (2.9) | 0.568 |
Revascularization, (%) | 92 (3.5) | 23 (2.6) | 30 (3.4) | 39 (4.4) | 0.114 |
Non-fatal MI, (%) | 52 (2.0) | 12 (1.4) | 17 (1.9) | 23 (2.6) | 0.168 |
Non-fatal stroke, n (%) | 17 (0.6) | 2 (0.2) | 4 (0.5) | 11 (1.2) | 0.019 |
